Report of the fifth meeting of the European Consortium 'Care for CMMRD' (C4CMMRD), Leiden, The Netherlands, July 6th 2019.

Published on Jan 1, 2021in Familial Cancer1.76
· DOI :10.1007/S10689-020-00194-1
Manon Suerink4
Estimated H-index: 4
(LEI: Leiden University),
Katharina Wimmer (Innsbruck Medical University)+ 14 AuthorsHans F. A. Vasen116
Estimated H-index: 116
(LEI: Leiden University)
Sources
Abstract
📖 Papers frequently viewed together
1 Citations
13 Citations
1 Author (J. Mallet)
References17
Newest
#1Helen ToledanoH-Index: 15
#2Naama Orenstein (TAU: Tel Aviv University)H-Index: 10
Last. Yael Goldberg (Rabin Medical Center)H-Index: 17
view all 15 authors...
Biallelic mutations in any of the four mismatch repair genes MSH2, MSH6, MLH1 and PMS2 result in one of the most aggressive childhood cancer predisposition syndromes, termed constitutional mismatch repair deficiency (CMMRD) syndrome. In addition to a very high tumour risk, the CMMRD phenotype is often characterised by the presence of signs reminiscent of neurofibromatosis type 1. Although paediatric systemic lupus erythematosus (pSLE) has been reported so far in three patients with CMMRD, it has...
3 CitationsSource
#1Maribel González-Acosta (ISCIII: Carlos III Health Institute)H-Index: 3
#2Fátima Rodríguez Marín (ISCIII: Carlos III Health Institute)H-Index: 9
Last. Marta Pineda (ISCIII: Carlos III Health Institute)H-Index: 28
view all 35 authors...
Introduction Lynch syndrome (LS) and constitutional mismatch repair deficiency (CMMRD) are hereditary cancer syndromes associated with mismatch repair (MMR) deficiency. Tumours show microsatellite instability (MSI), also reported at low levels in non-neoplastic tissues. Our aim was to evaluate the performance of high-sensitivity MSI (hs-MSI) assessment for the identification of LS and CMMRD in non-neoplastic tissues. Materials and methods Blood DNA samples from 131 individuals were grouped into ...
11 CitationsSource
#1Holly Lindsay (BCM: Baylor College of Medicine)H-Index: 9
#2Sarah Scollon (BCM: Baylor College of Medicine)H-Index: 15
Last. Angshumoy RoyH-Index: 21
view all 12 authors...
: Ultra-hypermutation (>100 mutations/Mb) is rare in childhood cancer genomes and has been primarily reported in patients with constitutional mismatch repair deficiency (CMMRD) caused by biallelic germline mismatch repair (MMR) gene mutations. We report a 5-yr-old child with classic clinical features of CMMRD and an ultra-hypermutated medulloblastoma with retained MMR protein expression and absence of germline MMR mutations. Mutational signature analysis of tumor panel sequencing data revealed a...
10 CitationsSource
#1Ceres Fernandez-Rozadilla (Grupo México)H-Index: 17
Last. Clara Ruiz-PonteH-Index: 28
view all 16 authors...
Lynch syndrome (LS) is the most common hereditary colorectal cancer (CRC) syndrome, caused by heterozygous mutations in the mismatch repair (MMR) genes. Biallelic mutations in these genes lead however, to constitutive mismatch repair deficiency (CMMRD). In this study, we follow the diagnostic journey of a 12-year old patient with CRC, with a clinical phenotype overlapping CMMRD. We perform molecular and functional assays to discard a CMMRD diagnosis then identify by exome sequencing and validati...
4 CitationsSource
#1Richard Gallon (Newcastle University)H-Index: 6
#2Barbara Mühlegger (Innsbruck Medical University)H-Index: 1
Last. Mauro Santibanez-Koref (Newcastle University)H-Index: 46
view all 35 authors...
: Constitutional mismatch repair deficiency (CMMRD) is caused by germline pathogenic variants in both alleles of a mismatch repair gene. Patients have an exceptionally high risk of numerous pediatric malignancies and benefit from surveillance and adjusted treatment. The diversity of its manifestation, and ambiguous genotyping results, particularly from PMS2, can complicate diagnosis and preclude timely patient management. Assessment of low-level microsatellite instability in nonneoplastic tissue...
16 CitationsSource
#1Manon Suerink (LEI: Leiden University)H-Index: 4
#2Tim Ripperger (MHH: Hannover Medical School)H-Index: 16
Last. Katharina WimmerH-Index: 30
view all 17 authors...
Constitutional mismatch repair deficiency (CMMRD) is a rare childhood cancer predisposition syndrome caused by biallelic germline mutations in one of four mismatch-repair genes. Besides very high tumour risks, CMMRD phenotypes are often characterised by the presence of signs reminiscent of neurofibromatosis type 1 (NF1). Because NF1 signs may be present prior to tumour onset, CMMRD is a legitimate differential diagnosis in an otherwise healthy child suspected to have NF1/Legius syndrome without ...
24 CitationsSource
#1Andrew Y. Shuen (U of T: University of Toronto)H-Index: 6
#2Stella LanniH-Index: 5
Last. Christopher E. Pearson (U of T: University of Toronto)H-Index: 54
view all 54 authors...
PurposeConstitutional mismatch repair deficiency (CMMRD) is a highly penetrant cancer predisposition syndrome caused by biallelic mutations in mismatch repair (MMR) genes. As several cancer syndromes are clinically similar, accurate diagnosis is critical to cancer screening and treatment. As genetic diagnosis is confounded by 15 or more pseudogenes and variants of uncertain significance, a robust diagnostic assay is urgently needed. We sought to determine whether an assay that directly measures ...
13 CitationsSource
#1Dung T. Le (Johns Hopkins University)H-Index: 53
#2Jennifer N. Durham (Johns Hopkins University)H-Index: 11
Last. Luis A. Diaz (Johns Hopkins University)H-Index: 120
view all 46 authors...
The genomes of cancers deficient in mismatch repair contain exceptionally high numbers of somatic mutations. In a proof-of-concept study, we previously showed that colorectal cancers with mismatch repair deficiency were sensitive to immune checkpoint blockade with antibodies to programmed death receptor–1 (PD-1). We have now expanded this study to evaluate the efficacy of PD-1 blockade in patients with advanced mismatch repair–deficient cancers across 12 different tumor types. Objective radiogra...
2,798 CitationsSource
#1Katharina WimmerH-Index: 30
#2Andreas Beilken (MHH: Hannover Medical School)H-Index: 8
Last. Christian P. Kratz (MHH: Hannover Medical School)H-Index: 30
view all 13 authors...
In a 14-year-old boy with polyposis and rectosigmoid carcinoma, we identified a novel POLE germline mutation, p.(Val411Leu), previously found as recurrent somatic mutation in ‘ultramutated’ sporadic cancers. This is the youngest reported cancer patient with polymerase proofreading-associated polyposis indicating that POLE mutation p.(Val411Leu) may confer a more severe phenotype than previously reported POLE and POLD1 germline mutations. The patient had multiple cafe-au-lait macules and a piloma...
30 CitationsSource
#1Sahra Bodo (French Institute of Health and Medical Research)H-Index: 6
#2Chrystelle Colas (French Institute of Health and Medical Research)H-Index: 25
Last. Alex Duval (French Institute of Health and Medical Research)H-Index: 43
view all 50 authors...
Background & Aims Patients with bi-allelic germline mutations in mismatch repair (MMR) genes ( MLH1 , MSH2 , MSH6 , or PMS2 ) develop a rare but severe variant of Lynch syndrome called constitutional MMR deficiency (CMMRD). This syndrome is characterized by early-onset colorectal cancers, lymphomas or leukemias, and brain tumors. There is no satisfactory method for diagnosis of CMMRD because screens for mutations in MMR genes are noninformative for 30% of patients. MMR-deficient cancer cells are...
62 CitationsSource
Cited By6
Newest
#1Kyaw Zin Thein (OHSU: Oregon Health & Science University)H-Index: 6
#2Steven Lemery (CDER: Center for Drug Evaluation and Research)H-Index: 16
Last. S. Kummar (OHSU: Oregon Health & Science University)H-Index: 9
view all 3 authors...
Summary: null In recent years, there has been remarkable progress in our understanding of cancer biology, host responses, and the concept of precision oncology. These advances have focused attention on biomarker-driven, tissue-agnostic drug development strategies. The recent approvals by the FDA of pembrolizumab for the treatment of unresectable or metastatic, microsatellite instability–high or deficient mismatch repair solid tumors, and more recently for the treatment of tumor mutational burden...
Source
Source
#2Anke K. Bergmann (Hochschule Hannover)H-Index: 15
Source
#2Isabel QuintanaH-Index: 2
Last. Laura ValleH-Index: 21
view all 6 authors...
Early-onset colorectal cancer (EOCRC), defined as that diagnosed before the age of 50, accounts for 10–12% of all new colorectal cancer (CRC) diagnoses. Epidemiological data indicate that EOCRC incidence is increasing, despite the observed heterogeneity among countries. Although the cause for such increase remains obscure, ≈13% (range: 9–26%) of EOCRC patients carry pathogenic germline variants in known cancer predisposition genes, including 2.5% of patients with germline pathogenic variants in ...
1 CitationsSource
#1Melyssa AronsonH-Index: 31
#2Chrystelle Colas (University of Paris)H-Index: 25
Last. Uri Tabori (U of T: University of Toronto)H-Index: 66
view all 14 authors...
Background Constitutional mismatch repair deficiency syndrome (CMMRD) is the most aggressive cancer predisposition syndrome associated with multiorgan cancers, often presenting in childhood. There is variability in age and presentation of cancers and benign manifestations mimicking neurofibromatosis type 1. Genetic testing may not be informative and is complicated by pseudogenes associated with the most commonly associated gene, PMS2. To date, no diagnostic criteria exist. Since surveillance and...
4 CitationsSource
#1Sameer Farouk Sait (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 4
#2Michael Walsh (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 113
Last. Matthias A. Karajannis (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 42
view all 3 authors...
Source